HERITAGE, SCIENCE & INTEGRITY
The Leeming family lineage carries more than six centuries of accumulated knowledge in natural remedies, botanical extraction, copper distillation, and early medicinal craft. These traditions, passed quietly through generations, form the hidden architecture of the modern company. What began as ancestral healing practices evolved into a refined scientific philosophy that blends inherited wisdom with contemporary bio‑active, longevity, and sustainability research.
Leeming & Co. was formally established in 1881 by Thomas Leeming, fulfilling the vision first expressed by his father, Joseph Leeming, in 1861. Throughout the late nineteenth and twentieth centuries, the company became a respected force in international pharmaceutical distribution. In 2026, the business was revived in England by Daryl Leeming Ross & Associates, restoring the family's historic commitment to ethical science, natural medicine, and global well‑being.
Our research focuses on transforming botanical compounds into nano‑crystal bio‑active forms, dramatically enhancing purity, absorption, and therapeutic performance. This approach allows natural medicine to operate with pharmaceutical precision, unlocking the full potential of plant‑based healing while maintaining the integrity of its origins. Our work extends into longevity bio‑science, exploring plant‑derived compounds that support vitality, cellular resilience, and long‑term well‑being.
Leeming & Co. continues to advance the frontier of natural nano‑crystal bio‑medicine through a disciplined programme of research, refinement, and controlled testing. Our work focuses on transforming naturally occurring compounds into highly stable nano‑crystal forms with significantly elevated bio‑activity, enabling new pathways for therapeutic performance and long‑term biological compatibility.
Our research pipeline now includes advanced natural mood stabiliser formulations engineered through nano‑crystal activation, delivering enhanced bio‑availability, improved consistency, and a more predictable therapeutic profile. These developments form part of our broader commitment to pioneering next‑generation natural medicines that align with ethical science and global health innovation.
Specialities: nano crystal research, testing and development
Ethics are the foundation of every decision we make. We employ non‑animal micro‑video testing, advanced in‑vitro analysis, transparent sourcing, and sustainable copper‑based distillation methods to ensure that every product meets the highest standards of safety and compassion. Our commitment to ethical practice is not a marketing stance - it is a continuation of the Leeming family's long‑standing belief that medicine must serve humanity responsibly.
The company specialises in pharmaceutical importing, bio‑active formulation, natural medicine research, copper and nano‑crystal distillation, ethical testing, clinical‑grade toiletries, and longevity‑focused bio‑science development. Our teams also work alongside expeditions in tribal and remote regions, studying ancestral medicinal systems and sustainable harvesting practices. This fieldwork allows us to ethically integrate ancient knowledge with modern scientific advancement.
Our future is defined by a single mission: to build the world's leading ethical pharmaceutical and natural‑medicine company, honouring Joseph Leeming's original 1861 vision. We aim to expand global access to advanced bio‑active therapies, pioneer new nano‑crystal and longevity technologies, refine copper‑based distillation methods, and deepen our sustainability commitments through responsible sourcing and expedition‑based research. The next chapter of Leeming & Co. is one of innovation, responsibility, and a renewed dedication to human well‑being.
Daryl Ross
OWNER
Finn Dempster
PARTNER
Karen Ballantyne
PARTNER
Logan Lerman
PARTNER
-
Christine Pemberton
PARTNER
Mervin Anderson
PARTNER
Catherine Cage
HEAD OF SCIENCE
-